Dbv Technologies Stock Analysis
| DBVT Stock | USD 9.46 0.32 3.27% |
DBV Technologies is undervalued with Real Value of 11.4 and Hype Value of 9.44. The main objective of DBV Technologies stock analysis is to determine its intrinsic value, which is an estimate of what DBV Technologies is worth, separate from its market price. There are two main types of DBV Technologies' stock analysis: fundamental analysis and technical analysis.
The DBV Technologies stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. DBV Technologies is usually not traded on Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday. DBV Stock trading window is adjusted to America/New York timezone.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DBV Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. DBV Stock Analysis Notes
The company recorded a loss per share of 5.75. DBV Technologies had not issued any dividends in recent years. The entity had 1:2 split on the 7th of June 2024. DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France. DBV Technologies operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. To learn more about DBV Technologies call Daniel Tass at 33 1 55 42 78 78 or check out https://www.dbv-technologies.com.DBV Technologies Investment Alerts
| DBV Technologies had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 2.57 M. Net Loss for the year was (113.92 M) with profit before overhead, payroll, taxes, and interest of 3.5 M. | |
| DBV Technologies currently holds about 247.97 M in cash with (104.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32. | |
| DBV Technologies has a frail financial position based on the latest SEC disclosures |
DBV Technologies Upcoming and Recent Events
| 7th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
DBV Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 273.67 M.Technical Drivers
As of the 27th of July, DBV Technologies shows the Downside Deviation of 4.43, mean deviation of 4.03, and Market Risk Adjusted Performance of 0.3885. DBV Technologies technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the entity's future prices.DBV Technologies Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. DBV Technologies middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for DBV Technologies. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
DBV Technologies Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DBV Technologies insiders, such as employees or executives, is commonly permitted as long as it does not rely on DBV Technologies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DBV Technologies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
DBV Technologies Outstanding Bonds
DBV Technologies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. DBV Technologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most DBV bonds can be classified according to their maturity, which is the date when DBV Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
DBV Technologies Predictive Daily Indicators
DBV Technologies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of DBV Technologies stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
DBV Technologies Forecast Models
DBV Technologies' time-series forecasting models are one of many DBV Technologies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary DBV Technologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About DBV Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how DBV Technologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling DBV shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as DBV Technologies. By using and applying DBV Stock analysis, traders can create a robust methodology for identifying DBV entry and exit points for their positions.
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France. DBV Technologies operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding DBV Technologies to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Additional Tools for DBV Stock Analysis
When running DBV Technologies' price analysis, check to measure DBV Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DBV Technologies is operating at the current time. Most of DBV Technologies' value examination focuses on studying past and present price action to predict the probability of DBV Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DBV Technologies' price. Additionally, you may evaluate how the addition of DBV Technologies to your portfolios can decrease your overall portfolio volatility.